Massachusetts Eye and Ear Infirmary Named Agilent Certified Service Provider | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies today named the Massachusetts Eye and Ear Infirmary as a certified service provider of the company's next-generation sequencing target enrichment and microarray-based comparative genomic hybridization solutions.

MEEI is an affiliate of Harvard Medical School and home to the school's Department of Opthalmology Ocular Genomics Institute. Using genomics and gene therapy, the institute is working to advance knowledge and treatment of blinding eye diseases, Agilent said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.